Active Ingredient History
Cannabis, also known as marijuana or weed among other names, is a psychoactive drug from the cannabis plant. Native to Central or South Asia, the cannabis plant has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries. Tetrahydrocannabinol (THC) is the main psychoactive component of cannabis, which is one of the 483 known compounds in the plant, including at least 65 other cannabinoids, such as cannabidiol (CBD). Cannabis can be used by smoking, vaporizing, within food, or as an extract. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acquired Immunodeficiency Syndrome (Phase 2)
Acute Pain (Phase 3)
Adolescent (Phase 2)
Affect (Phase 2)
Aging (Phase 2)
Alcohol Drinking (Phase 2)
Alcohol-Induced Disorders (Phase 1/Phase 2)
Alcoholism (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2/Phase 3)
Analgesics, Opioid (Phase 4)
Anemia, Sickle Cell (Phase 2)
Anxiety (Phase 2)
Arthritis, Psoriatic (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Autism Spectrum Disorder (Phase 3)
Autistic Disorder (Phase 2)
Automobile Driving (Phase 2)
Back Pain (Phase 3)
Bipolar Disorder (Phase 2)
Brain Injuries, Traumatic (Phase 3)
Breast Neoplasms (Phase 1)
Cancer Pain (Phase 1/Phase 2)
Cannabidiol (Phase 2)
Cannabinoids (Phase 2/Phase 3)
Cannabis (Phase 4)
Carcinoma (Phase 1)
Chronic Pain (Phase 3)
Chronic Traumatic Encephalopathy (Phase 2)
Cocaine-Related Disorders (Phase 4)
Cognitive Dysfunction (Phase 2)
Colitis, Ulcerative (Phase 2)
Constipation (Phase 1)
Coronavirus (Phase 2)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2)
Crohn Disease (Phase 2)
Dementia (Phase 2/Phase 3)
Depression (Phase 2)
Depressive Disorder, Major (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetic Neuropathies (Phase 3)
Diagnosis, Dual (Psychiatry) (Phase 1)
Driving Under the Influence (Phase 1/Phase 2)
Dronabinol (Phase 2)
Drug Interactions (Phase 1)
Drug-Related Side Effects and Adverse Reactions (Phase 1/Phase 2)
Drug Resistant Epilepsy (Phase 3)
Dyspnea (Phase 2)
Electromyography (Phase 2/Phase 3)
Endometriosis (Phase 2/Phase 3)
Epilepsy (Phase 2)
Exercise (Phase 2)
Feeding and Eating Disorders (Phase 3)
Fibromyalgia (Phase 4)
Gastrointestinal Diseases (Phase 1)
Glaucoma (Phase 2)
Glioblastoma (Phase 1)
Health Services for the Aged (Phase 1)
Healthy Volunteers (Phase 1)
Heart Disease Risk Factors (Early Phase 1)
Hepatitis C (Phase 2)
Hidradenitis Suppurativa (Phase 2)
HIV (Phase 2)
HIV Infections (Phase 2)
Hyperalgesia (Phase 2)
Hypotension (Phase 1)
Inflammatory Bowel Diseases (Phase 2)
Low Back Pain (Phase 3)
Lung Neoplasms (Phase 1)
Marijuana Abuse (Phase 2)
Marijuana Smoking (Phase 2)
Marijuana Use (Phase 2)
Medical Oncology (Phase 2/Phase 3)
Migraine Disorders (Phase 2)
Motor Neuron Disease (Phase 2/Phase 3)
Mouth Neoplasms (Phase 1)
Multiple Sclerosis (Phase 3)
Muscle Spasticity (Phase 3)
Myofascial Pain Syndromes (Phase 2/Phase 3)
Nausea (Phase 2)
Neck Pain (Phase 3)
Neoplasms (Phase 3)
Neuralgia (Phase 3)
Neuralgia, Postherpetic (Phase 1/Phase 2)
Nicotine (Phase 1)
Obesity (Phase 2)
Obsessive-Compulsive Disorder (Phase 1/Phase 2)
Opiate Overdose (Phase 2)
Opioid-Related Disorders (Phase 2)
Osteoarthritis, Knee (Phase 2)
Pain (Phase 3)
Pain, Postoperative (Phase 3)
Pain Threshold (Phase 2)
Palliative Care (Phase 2/Phase 3)
Paraplegia (Phase 3)
Parkinson Disease (Phase 2)
Pelvic Pain (Phase 2/Phase 3)
Peripheral Nerve Injuries (Phase 3)
Peripheral Nervous System Diseases (Phase 3)
Phantom Limb (Phase 3)
Pharmacokinetics (Phase 1)
Pharmacology (Phase 1)
Phobia, Social (Phase 2)
Protein-Energy Malnutrition (Phase 3)
Psoriasis (Phase 1)
Psychotic Disorders (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Quality of Life (Phase 2/Phase 3)
Reflex Sympathetic Dystrophy (Phase 1/Phase 2)
Renal Dialysis (Phase 3)
Respiratory Insufficiency (Phase 4)
Retinal Degeneration (Early Phase 1)
Retinitis Pigmentosa (Early Phase 1)
Safety (Phase 1)
Schizophrenia (Phase 1)
Sciatica (Phase 1/Phase 2)
Seizures (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Sleep Disorders, Intrinsic (Phase 2)
Sleep Wake Disorders (Phase 2)
Smoking (Early Phase 1)
Spinal Cord Diseases (Phase 2/Phase 3)
Spinal Cord Injuries (Phase 2/Phase 3)
Stress Disorders, Post-Traumatic (Phase 2)
Stroke (Phase 3)
Substance-Related Disorders (Phase 1)
Tachycardia (Phase 1)
Temporomandibular Joint Disorders (Phase 2/Phase 3)
Tinnitus (Phase 1)
Tobacco Use (Phase 2)
Tourette Syndrome (Phase 2)
Traumatology (Phase 3)
Vaping (Phase 2)
Vomiting (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
